Abstract
Skin delivery is more advantageous for drug administration than other routes since it is more compliant and can avoid the first-pass metabolic effect. More importantly, it can ensure stable blood level of transdermal drugs for a long period of time, avoiding fluctuation and reducing side effects. However, it is restricted by the barrier function of the stratum corneum. Therefore, significant attention has been paid to developing methods to modify the kinetics of skin drug delivery and expand the range of drugs that can be used for transdermal delivery. Novel mechanisms of increasing the intercellular and appendages penetration pathways have also been developed. This review focuses on chemical penetration enhancers, physical permeabilization (sonophoresis, iontophoresis and microneedles) and novel nanocarriers for skin delivery. Recent developments on skin delivery are also discussed.
Keywords: Chemical penetration enhancer, nanocarrier, physical permeabilization, skin barrier.
Current Pharmaceutical Design
Title:Breaking the Skin Barrier: Achievements and Future Directions
Volume: 21 Issue: 20
Author(s): Hui Zhang, Yingjie Zhai, Xiaoye Yang and Guangxi Zhai
Affiliation:
Keywords: Chemical penetration enhancer, nanocarrier, physical permeabilization, skin barrier.
Abstract: Skin delivery is more advantageous for drug administration than other routes since it is more compliant and can avoid the first-pass metabolic effect. More importantly, it can ensure stable blood level of transdermal drugs for a long period of time, avoiding fluctuation and reducing side effects. However, it is restricted by the barrier function of the stratum corneum. Therefore, significant attention has been paid to developing methods to modify the kinetics of skin drug delivery and expand the range of drugs that can be used for transdermal delivery. Novel mechanisms of increasing the intercellular and appendages penetration pathways have also been developed. This review focuses on chemical penetration enhancers, physical permeabilization (sonophoresis, iontophoresis and microneedles) and novel nanocarriers for skin delivery. Recent developments on skin delivery are also discussed.
Export Options
About this article
Cite this article as:
Zhang Hui, Zhai Yingjie, Yang Xiaoye and Zhai Guangxi, Breaking the Skin Barrier: Achievements and Future Directions, Current Pharmaceutical Design 2015; 21 (20) . https://dx.doi.org/10.2174/1381612821666150428124406
DOI https://dx.doi.org/10.2174/1381612821666150428124406 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Do We have the Evidence to Repurpose Levamisole for Treatment of COVID 19?
Current Drug Therapy Functional Characteristic of Snake Venom Disintegrins: Potential Therapeutic Implication
Current Pharmaceutical Design The Role of T-Type Calcium Channels in Peripheral and Central Pain Processing
CNS & Neurological Disorders - Drug Targets Imaging Epigenetics in Alzheimer’s Disease
Current Pharmaceutical Design Flavone Analogues as Antimicrobial Agents
Recent Patents on Inflammation & Allergy Drug Discovery Niosomal Gel for Site-Specific Sustained Delivery of Anti-Arthritic Drug: In Vitro-In Vivo Evaluation
Current Drug Delivery Role of IL-10 in the Resolution of Airway Inflammation
Current Molecular Medicine Anticancer Drugs in Liposomal Nanodevices: A Target Delivery for a Targeted Therapy
Current Topics in Medicinal Chemistry Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment
Current Neuropharmacology Dietary Approaches to Attain Fish Health with Special Reference to their Immune System
Current Pharmaceutical Design Editorial:
Drug Metabolism Letters Inhibition of Raf Kinase in the Treatment of Acute Myeloid Leukemia
Current Pharmaceutical Design Diabetes-induced Epigenetic Signature in Vascular Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets The Physiology of Learning and Memory: Role of Peptides and Stress
Current Protein & Peptide Science Aggregation of Recombinant Monoclonal Antibodies and Its Role in Potential Immunogenicity
Current Pharmaceutical Biotechnology The Effects of Caffeine on the Cholinergic System
Mini-Reviews in Medicinal Chemistry Impact of DNA Vector Topology on Non-Viral Gene Therapeutic Safety and Efficacy
Current Gene Therapy Nanoparticles Adjuvants in Allergology: New Challenges and Pitfalls
Current Pharmaceutical Design Antagonism of Eosinophil Accumulation in Asthma
Recent Patents on Inflammation & Allergy Drug Discovery Meet the Editor
Reviews on Recent Clinical Trials